Timaran earns first Clagett Professorship in Vascular Surgery
By Lisa Ashley Warshaw
Dr. Carlos Timaran, Associate Professor of Surgery, has been named the first holder of the G. Patrick Clagett Professorship in Vascular Surgery.
“This is probably one of the most important recognitions in my life,” Dr. Timaran said. “It means a lot because of what Dr. Clagett represents. He symbolizes the best possible care for patients. He was an outstanding teacher and mentor, and also the finest surgeon with the best skills.”
When it came time to name the first holder of the Clagett Professor, the choice was an easy one, said Dr. R. James Valentine, Chief of the Division of Vascular Surgery.
Dr. Timaran is one of the “most talented endovascular surgeons of the 21st century,” Dr. Valentine said. “He is an incredibly important new academic superstar.”
Gifts from various donors – including former residents and fellows who trained under Dr. Clagett – established the professorship to honor him upon his retirement in 2011. Dr. Clagett helped build and later served as Chief of the Division of Vascular Surgery, which under his leadership became the nationally renowned program it is today.
“Dr. Clagett is a world-class surgeon, outstanding educator, and accomplished researcher,” Dr. Valentine said. “He is a highly professional physician and role model for everyone around him.”
Dr. Timaran, an internationally recognized expert in advanced endovascular techniques, joined UT Southwestern in 2004. He has authored more than 65 articles in peer-reviewed journals, written 82 peer-reviewed abstracts, and has given more than 200 lectures and presentations around the world.
Dr. Timaran also is a leader in carotid artery stenting, and is the institutional principal investigator for the National Institutes of Health-funded Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST). CREST is studying the outcomes between traditional surgery and interventional techniques in the treatment of carotid disease, one of the main causes of stroke.
Dr. Timaran is one of only a handful of surgeons in the U.S. who performs fenestrated endovascular grafts, in which a stent is inserted into a major artery with customized fenestrations, or windows, that are placed from the main stent to the renal and intestinal arteries. This technique has expanded the application of interventional therapy to patients with complex aneurysms who previously were not considered candidates for minimally invasive techniques.
Such innovations have greatly benefited patients with significant reductions in discomfort, morbidity, and mortality that may accompany surgical treatment.
“Dr. Timaran is very much like Dr. Clagett in that he is a world-class surgeon, has contributed a huge amount to the medical literature, and is an outstanding educator,” Dr. Valentine said.
Said Dr. Timaran, “While I identify myself with Dr. Clagett in a lot of ways, I am humbled that people would compare me to him and his achievements. I think I am still a far way from that, but I strive to be the outstanding surgeon and physician he was.”
Dr. Clagett pioneered the Clagett procedure, a surgical technique that repairs infected aortic graft infections, which once often led to amputation and death. The procedure, now considered standard, replaces an infected graft with a patient’s own femoral veins.
Dr. Clagett said the professorship in his name was an unexpected honor.
“I am both humbled and grateful, and would like to extend my heartfelt appreciation to all the friends, colleagues, and former trainees who contributed to the professorship,” he said. “Actually, I am doubly honored because I could not think of a better person to be the holder than Dr. Carlos Timaran.”
Dr. Valentine holds the Alvin Baldwin Jr. Chair in Surgery.